Improved Blood Flow: BPC-157 stimulates angiogenesis, which forms new capillaries around injured areas
In a formal review, the agency concluded that BPC-157: Lacks sufficient safety data and has not been shown to be safe or effective in humans FDA Compounding Memorandum, 2023 The FDA also lists BPC-157 as ineligible for 503B compounding , which prohibits it from being added to compounded medications by outsourcing facilities
Unlock the Science Ingredient How it Works Accelerates healing of muscles, tendons, ligaments, and joints by activating growth factors at injury sites Repairs the gut lining and reduces GI inflammation for whole-body recovery support Stimulates angiogenesis and nerve regeneration to fully restore tissue function Reduces systemic inflammation to improve mobility, comfort, and recovery speed Promotes body-wide tissue repair and cellular regeneration through actin upregulation Reduces inflammation and accelerates healing of chronic and acute injuries Improves flexibility, range of motion, and muscle elasticity post-injury Works synergistically with BPC-157 to amplify recovery beyond what either peptide achieves alone Drug Facts Peptide therapies are not FDA-approved for anti-aging but are commonly prescribed off-label in regenerative and hormone optimization clinics
Retatrutide activates three receptor systems simultaneously: GLP-1, GIP, and glucagon receptors
Amount: 60 Enteric Coated Capsules Per Bottle
